[Hematologic diseases and opsonic alpha 2-macroglobulin. A correlative study].
We have investigated the opsonic alpha 2 Macroglobulin in Patients with various haematological diseases by means of turbidimetry. Patients with a poor prognosis tended to have lower levels. Therapeutic implications are discussed.
D000328:Adult; D000368:Aged; D000745:Anemia, Hemolytic, Congenital / Q000097:blood; D005260:Female; D006402:Hematologic Diseases / Q000097:blood*; D006689:Hodgkin Disease / Q000097:blood; D006801:Humans; D007943:Leukemia, Hairy Cell / Q000097:blood; D007945:Leukemia, Lymphoid / Q000097:blood; D007951:Leukemia, Myeloid / Q000097:blood; D008297:Male; D008875:Middle Aged; D009895:Opsonin Proteins / Q000032:analysis*; D011379:Prognosis; D000511:alpha-Macroglobulins / Q000378:metabolism*
D009895:Opsonin Proteins; D000511:alpha-Macroglobulins
Hämoblastosen und opsonierendes alpha 2-Makroglobulin. Eine korrelative Studie.